// App-Quantinova.ai

501 : Adjuvant denosumab in early breast cancer: First results from the international multicenter randomized phase III placebo controlled D-CARE study.

Researchers

Presenter

  • Robert E. Coleman

Principal Investigators

  • Dianne Finkelstein

  • Carlos H. Barrios

  • Miguel Martin

  • Hiroji Iwata

  • John A. Glaspy

  • Ying Zhou

  • Danielle Jandial

  • Arlene Chan

Medical Centers

  • University of Sheffield, Weston Park Hospital, Sheffield, United Kingdom

  • Massachusetts General Hosp Harvard Medcl School, Boston, MA

  • Latin American Cooperative Oncology Group, Porto Alegre, Brazil

  • Hospital Universitario Quiron Madrid, Madrid, Spain

  • Aichi Cancer Center Hospital, Nagoya, Japan

  • University of California, Los Angeles and the Jonsson Comprehensive Cancer Center, Los Angeles, CA

  • Amgen Inc, Thousand Oaks, CA

  • Amgen Inc, Thousand Oaks, CA

  • Breast Cancer Research Centre - WA & Curtin University, Perth, Australia

Locations

  • Brazil

  • Japan

  • Spain

  • United Kingdom

  • Australia

  • United States

Companies

  • Amgen Inc.

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Denosumab

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Multinational

  • Multicenteric

  • Controlled

Phase

  • III

Study Id's

  • NCT01077154

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved